Meredith Crabtree Overview:
This webinar explores how sustainability and environmental considerations intersect with quality and regulatory requirements in FDA-regulated industries. We will review typical environmental impacts in pharma, biotech, device, and related sectors, then discuss strategies to reduce waste, energy use, and emissions without compromising product quality or compliance. The session will show how to embed sustainability into QMS processes such as change control, risk management, supplier oversight, and validation. Participants will gain practical ideas, examples, and tools to evaluate proposed sustainability initiatives, justify them to stakeholders, and document them in a way that can withstand regulatory scrutiny.
Why you should Attend:
If sustainability discussions in your organization are happening separately from quality and regulatory planning, you may be missing both risk and opportunity. Poorly evaluated changes can jeopardize sterility, stability, or supply reliability; doing nothing can increase costs, waste, and reputational risk with regulators, customers, and investors. This webinar will help you navigate the tension between “green” initiatives and compliant operations-so you can pursue sustainability goals without creating hidden quality or regulatory problems
Areas Covered in the Session:
Who Will Benefit:
Meredith L. Crabtree has over 30 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical Device, Cosmetics, Supplements, and Animal Health. This includes manufacturing, packaging, labelling and distribution operations. Meredith is the owner of MLKC Consulting is s a Quality Consultant specializing in product label reviews, 3rd party inspections, Consent Decree and Recall support. She also performs regulatory assessments and Quality trainings.